Farmacy

Dec 28 2017

Hundreds of Charlotte jobs to be lost as pharmaceutical plant closes #healthcare #industry #news

#pharmaceutical companies in charlotte nc # Hundreds of Charlotte jobs to be lost as pharmaceutical plant closes An Irish pharmaceutical company is closing a Charlotte manufacturing plant as part of a broad restructuring, a move that will cost 390 local jobs. Qualitest Pharmaceuticals, a subsidiary of Dublin-based Endo International, announced last week that it is closing the facility in Charlotte and reducing its Huntsville, Ala. workforce to cut costs. In Charlotte, the company operates an 88,000-square-foot manufacturing plant that produces tablets and capsules of generic medicines. The facility is located on Woodpark Boulevard, off Interstate 85 north of uptown. “The …

Dec 26 2017

Even for busy doctors, nothing is as good as a rep – for getting pharma

#pharma info # Even for busy doctors, nothing is as good as a rep for getting pharma info If you’re a pharma sales rep, chances are, you’re walking through a fog of existential angst. If you’re not questioning your existence, worrying that you’ll be laid off, or wondering whether the doctors in your territory will stop seeing reps, you know other reps who are. All the surveys and studies–doctors like seeing reps, doctors prefer to read, doctors are unduly influenced, doctors aren’t, e-detailing will or won’t replace reps–probably don’t help, either. But you’ve probably been around long enough to have …

Dec 22 2017

Alnylam Soars as Drugmakers Circle Rival Biotechnology Company #bal #pharma

#biotechnology company # Alnylam Soars as Drugmakers Circle Rival Biotechnology Company Alnylam Pharmaceuticals Inc. rose as much as 12 percent, the most in more than a year, after Sanofi, which owns a stake in the company, accelerated its pursuit of another drugmaker as potential rivals circled. suggesting demand for biotechnology acquisitions may be picking up. Sanofi Chief Executive Officer Olivier Brandicourt proposed eight independent candidates to replace Medivation Inc.’s board after the sitting members spurned the French company’s takeover offer. Meanwhile, people familiar with the Medivation chase said Celgene Corp. and Gilead Sciences Inc. were both considering bids for the …

Dec 22 2017

Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #biotech #pharma

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …

Dec 6 2017

REGENICS AS #penn #pharma

#biotechnology companies # Board of directors Tore Heldrup Rasmussen. MBA, Founder, Chairman of the Board. Mr. Rasmussen has been heading up several successful biotechnology companies prior to co-founding Regenics. Mr. Rasmussen brings many years of experience in strategy development and consumer products, as a Partner in MarkUp Consulting in Oslo and through tenures with Procter & Gamble and Orkla Foods (Norway). Mr. Rasmussen has an MBA degree from the University of Michigan. Harald Nordal. MSc, MBA. Mr. Nordal serves on the Regenics Board of Directors and is the managing Director of Life Capitol AS, a Norwegian based holding company located …

Dec 1 2017

Even for busy doctors, nothing is as good as a rep – for getting pharma

#pharma info # Even for busy doctors, nothing is as good as a rep for getting pharma info If you’re a pharma sales rep, chances are, you’re walking through a fog of existential angst. If you’re not questioning your existence, worrying that you’ll be laid off, or wondering whether the doctors in your territory will stop seeing reps, you know other reps who are. All the surveys and studies–doctors like seeing reps, doctors prefer to read, doctors are unduly influenced, doctors aren’t, e-detailing will or won’t replace reps–probably don’t help, either. But you’ve probably been around long enough to have …

Nov 23 2017

As Pharma Jobs Leave N #pharmaceutical #marketing #companies

#pharmajobs # As Pharma Jobs Leave N.J. Office Space Ghost Towns Remain Tom Stanton of the real estate firm Jones Lang LaSalle shows off empty lab space at Roche in Nutley, N.J. New Jersey used to be known as “the nation’s medicine chest,” but over the past two decades, many of the state’s pharmaceutical industry jobs have dried up or moved elsewhere, and left millions of square feet of office space, warehouses and laboratories sitting empty. One of those sites is the 116-acre corporate campus of the Swiss drugmaker Roche in Nutley, N.J. There are dozens of buildings on this …

Nov 22 2017

Tris Pharma Receives FDA Approval of Dyanavel™ XR (amphetamine) CII as Once-Daily Liquid for #map

#tris pharma # Tris Pharma Receives FDA Approval of Dyanavel™ XR (amphetamine) CII as Once-Daily Liquid for Treatment of ADHD in Children MONMOUTH JUNCTION, N.J. Oct. 20, 2015 /PRNewswire/ — Tris Pharma, Inc. (“Tris”) announced that the U.S. Food and Drug Administration (“FDA”) has approved Dyanavel XR (amphetamine), extended-release oral suspension, CII, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children 6 years and older. With this approval, Dyanavel XR becomes the only once-daily, extended release amphetamine-based oral liquid approved for the treatment of ADHD in children. The approval is based on a Phase III randomized, placebo-controlled, laboratory classroom efficacy …

Sep 19 2017

Alnylam Soars as Drugmakers Circle Rival Biotechnology Company #pharmaceutical #publications

#biotechnology company # Alnylam Soars as Drugmakers Circle Rival Biotechnology Company Alnylam Pharmaceuticals Inc. rose as much as 12 percent, the most in more than a year, after Sanofi, which owns a stake in the company, accelerated its pursuit of another drugmaker as potential rivals circled. suggesting demand for biotechnology acquisitions may be picking up. Sanofi Chief Executive Officer Olivier Brandicourt proposed eight independent candidates to replace Medivation Inc.’s board after the sitting members spurned the French company’s takeover offer. Meanwhile, people familiar with the Medivation chase said Celgene Corp. and Gilead Sciences Inc. were both considering bids for the …

Sep 19 2017

7 Easiest Countries To Teach English Without A College Degree – Insider Monkey #11 #highest

# Dear Valued Visitor, We have noticed that you are using an ad blocker software. Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login . We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member. Published on …